Akèy › Ensifizyans kadyak › Maryland
Etid klinik pou Ensifizyans kadyak nan Maryland
28 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Johns Hopkins University, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06517186A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Annapolis
- Research Site, Baltimore
- Research Site, Lanham
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University of Maryland Medical Center, Baltimore
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Ascension Saint Agnes Heart Care, Baltimore
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Ascension Saint Agnes Heart Care, Baltimore
- Metropolitan Cardiovascular Consultants, Beltsville
- Capitol Cardiology Associates, Lanham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06935370Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins University, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Baltimore
- Research Site, Beltsville
- Research Site, Lutherville-Timonium
- ak 1 plis
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060Technical Development of Cardiovascular Magnetic Resonance Imaging
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT04927429Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Rockville
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baltimore, MD Investigative Site 10101, Baltimore
- Bowie, MD Investigative Site 10020, Bowie
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Maryland Medical Center, Baltimore
- The Johns Hopkins Hospital, Baltimore
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 100 · Tout sèks · Mizajou Sep 8, 2026 · NCT03581318A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 106, Baltimore
Ap rekriteFaz 2
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814Rilonacept in Subjects With Cardiac Sarcoidosis
- Johns Hopkins University, Baltimore
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT06660732Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Bethesda
- Hyattsville
- Salisbury
- ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- MedStar Health Research Institute, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Ascension Saint Agnes Heart Ca, Baltimore
- Mercy Medical Center, GI Research, Baltimore
- Flourish Research Bowie, Bowie
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Johns Hopkins Medical Institution, Baltimore
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
- Johns Hopkins Center for Health Equity, Baltimore
- Johns Hopkins University Comstock Center, Hagerstown
Ap rekrite
Laj 30 a 70 · Tout sèks · Mizajou Jul 15, 2026 · NCT06364644PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- MedStar, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Ascension Saint Agnes Heart Care, Baltimore
- Chesapeake Cardiac Care, Bowie
- Flourish Research - Bowie, Bowie
Ap rekriteFaz 2
Laj 18 a 79 · Tout sèks · Mizajou May 27, 2026 · NCT06991257The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Johns Hopkins, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
- Johns Hopkins Medical Institutions, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 9, 2026 · NCT00181259Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- Johns Hopkins University, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06932081Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University School of Medicine, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Jan 20, 2026 · NCT00733590Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
- Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Jan 12, 2026 · NCT06299436Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Johns Hopkins University, Baltimore
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- John Hopkins University School of Medicine, Baltimore
Ap rekriteEtid obsèvasyon
Laj 14 a 65 · Tout sèks · Mizajou Nov 1, 2024 · NCT06311708Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.